PET of serotonin 1A receptors and cerebral glucose metabolism for temporal lobectomy

Journal of Nuclear Medicine

Volumn 53, Issue 9, 2012, Pages 1375-1382

  Theodore, William H ^a   Martinez, Ashley R ^a   Khan, Omar I ^a   Liew, Clarissa J ^a   Auh, Sungyoung ^a   Dustin, Irene M ^a   Heiss, John ^a   Sato, Susumu ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Glucosemetabolism; Positron emission tomography; Serotonin receptors; Temporal lobe epilepsy

Indexed keywords

4 FLUORO N 2 [4 (2 METHOXYPHENYL)PIPERAZIN 1] ETHYL N (2 PYRIDYL)CYCLOHEXANE CARBOXAMIDE F 18; FLUORODEOXYGLUCOSE F 18; GLUCOSE; RADIOPHARMACEUTICAL AGENT; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN MAPPING; BRAIN SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ELECTROCORTICOGRAPHY; ELECTROENCEPHALOGRAPHY; FEMALE; FOLLOW UP; GLUCOSE METABOLISM; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TEMPORAL LOBE EPILEPSY; TEMPORAL LOBECTOMY; TREATMENT RESPONSE;

ADULT; CYCLOHEXANES; ELECTROENCEPHALOGRAPHY; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROSURGICAL PROCEDURES; PIPERAZINES; POSITRON-EMISSION TOMOGRAPHY; RECEPTOR, SEROTONIN, 5-HT1A; RETROSPECTIVE STUDIES; SEROTONIN 5-HT1 RECEPTOR ANTAGONISTS; TEMPORAL LOBE;

EID: 84866173318     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.112.103093     Document Type: Article

References (36)

1. Wiebe S, Blume WT, Girvin JP, Eliasziw M. Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group: a randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345:311-318.
2. Uijl SG, Leijten FS, Arends JB, Parra J, van Huffelen AC, Moons KG. Prognosis after temporal lobe epilepsy surgery: the value of combining predictors. Epilepsia. 2008;49:1317-1323.
3. Duncan J. The current status of neuroimaging for epilepsy. Curr Opin Neurol. 2009;22:179-184.
4. Richardson M. Update on neuroimaging in epilepsy. Expert Rev Neurother. 2010;10:961-973.
5. Toczek MT, Carson RE, Lang L, et al. PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy. Neurology. 2003;60:749-756.
6. 18F]MPPF-PET study. Brain. 2004;127:900-913.
7. Savic I, Lindstrom P, Gulyas B, et al. Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy. Neurology. 2004;62:1343-1351.
8. 1a receptors are reduced in temporal lobe epilepsy after partial volume correction. J Nucl Med. 2005;46:1128-1135.
9. Assem-Hilger E, Lanzenberger R, Savli M, et al. Central serotonin 1A receptor binding in temporal lobe epilepsy: a [carbonyl-(11)C]WAY-100635 PET study. Epilepsy Behav. 2010;19:467-473.
10. Clinckers R, Smolders I, Meurs A, et al. Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D and 5-HT receptors. J Neurochem. 2004;89:834-843.
11. Deng PY, Lei S. Serotonin increases GABA release in rat entorhinal cortex by inhibiting interneuron TASK-3 K1 channels. Mol Cell Neurosci. 2008;39:273-284.
12. 18F-FDG PET in MRI negative temporal lobe epilepsy. Epilepsia. 2009;50:234-239.
13. Spencer SS, Berg AT, Vickrey BG, et al; Multicenter Study of Epilepsy Surgery. Health-related quality of life over time since resective epilepsy surgery. Ann Neurol. 2007;62:327-334.
14. Devinsky O, Barr WB, Vickrey BG, et al. Changes in depression and anxiety after resective surgery for epilepsy. Neurology. 2005;65:1744-1749.
15. 18F-FDG PET in preoperative epilepsy surgery evaluation for patients with temporal lobe epilepsy: a meta-analysis. Seizure. 2007;16:509-520.
16. 18F]-fluoro-D-deoxyglucose positron emission tomography in screening for temporal lobe epilepsy surgery. Epilepsia. 2007;48:2121-2129.
17. Immonen A, Jutila L, Muraja-Murro A, et al. Long-term epilepsy surgery outcomes in patients with MRI-negative temporal lobe epilepsy. Epilepsia. 2010;51:2260-2269.
18. 18F-FDG PET in the presurgical evaluation of medically refractory focal epilepsy. J Nucl Med. 2008;49:931-937.
19. Vinton AB, Carne R, Hicks RJ, et al. The extent of resection of FDG-PET hypometabolism relates to outcome of temporal lobectomy. Brain. 2007;130:548-560.
20. Boling WW, Lancaster M, Kraszpulski M, Palade A, Marano G, Puce A. Fluorodeoxyglucose-positron emission tomographic imaging for the diagnosis of mesial temporal lobe epilepsy. Neurosurgery. 2008;63:1130-1138.
21. Didelot A, Ryvlin P, Lothe A, Merlet I, Hammers A, Mauguiere F. PET imaging of brain 5-HT1A receptors in the preoperative evaluation of temporal lobe epilepsy. Brain. 2008;131:2751-2764.
22. McIntosh AM, Kalnins RM, Michell LA, et al. Temporal lobectomy: long-term seizure outcome, late recurrence and risks for seizure recurrence. Brain. 2004;127:2018-2030.
23. Bien CG, Szinay M, Wagner J, Clusmann H, Becker AJ, Urbach H. Characteristics and surgical outcomes of patients with refractory magnetic resonance imaging-negative epilepsies. Arch Neurol. 2009;66:1491-1499.
24. McGonigal A, Bartolomei F, Regis J, et al. Stereoelectroencephalography in presurgical assessment of MRI-negative epilepsy. Brain. 2007;130:3169-3183.
25. Carne RP, O'Brien TJ, Kilpatrick CJ, et al. MRI-negative PET-positive temporal lobe epilepsy: a distinct surgically remediable syndrome. Brain. 2004;127:2276-2285.
26. Fong JS, Jehi L, Najm I, Prayson RA, Busch R, Bingaman W. Seizure outcome and its predictors after temporal lobe epilepsy surgery in patients with normal MRI. Epilepsia. 2011;52:1393-1401.
27. 18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy: a prospective study in 100 patients. Brain. 1998;121:2067-2081.
28. 11C]flumazenil binding in temporal lobe epilepsy with normal MRI. Brain. 2002;125:2257-2271.
29. Hammers A, Koepp MJ, Brooks DJ, Duncan JS. Periventricular white matter flumazenil binding and postoperative outcome in hippocampal sclerosis. Epilepsia. 2005;46:944-948.
30. Theodore WH, Sato S, Kufta C, Balish MB, Bromfield EB, Leiderman DB. Temporal lobectomy for uncontrolled seizures: the role of positron emission tomography. Ann Neurol. 1992;32:789-794.
31. Manno EM, Sperling MR, Ding X, et al. Predictors of outcome after anterior temporal lobectomy: positron emission tomography. Neurology. 1994;44:2331-2336.
32. Wong CY, Geller EB, Chen EQ, et al. Outcome of temporal lobe epilepsy surgery predicted by statistical parametric PET imaging. J Nucl Med. 1996;37:1094-1100.
33. Lin TW, de Aburto MA, Dahlbom M, et al. Predicting seizure-free status for temporal lobe epilepsy patients undergoing surgery: prognostic value of quantifying maximal metabolic asymmetry extending over a specified proportion of the temporal lobe. J Nucl Med. 2007;48:776-782.
34. Ohta Y, Nariai T, Ishii K, et al. Voxel- and ROI-based statistical analyses of PET parameters for guidance in the surgical treatment of intractable mesial temporal lobe epilepsy. Ann Nucl Med. 2008;22:495-503.
35. Didelot A, Mauguiere F, Redoute J, et al. Voxel-based analysis of asymmetry index maps increases the specificity of 18F-MPPF PET abnormalities for localizing the epileptogenic zone in temporal lobe epilepsies. J Nucl Med. 2010;51:1732-1739.
36. Gaillard WD, Cross JH, Duncan JS, Stefan H, Theodore WH; Task Force on Practice Parameter Imaging Guidelines for International League Against Epilepsy, Commission for Diagnostics. Epilepsy imaging study guideline criteria: commentary on diagnostic testing study guidelines and practice parameters. Epilepsia. 2011;52:1750-1756.